Cassava Sciences, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
SAVA Nasdaq 2830 www.cassavasciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cassava Sciences, Inc.

Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More - Nov 29th, 2024 6:51 pm
A Post-Mortem on Cassava Sciences - Nov 26th, 2024 9:36 pm
SAVA Stock Plunges 84% on Alzheimer's Drug Failure in Late-Stage Study - Nov 26th, 2024 6:42 pm
Down -83.93% in 4 Weeks, Here's Why You Should You Buy the Dip in Cassava Sciences (SAVA) - Nov 26th, 2024 2:35 pm
Cassava Sciences Plummets 84% After Embattled Alzheimer's Drug Flops - Nov 25th, 2024 9:15 pm
Cassava Sciences plummets over 80% on Alzheimer's trial fail - Nov 25th, 2024 8:57 pm
Cassava Sciences stock plummets after Phase III Alzheimer’s fail - Nov 25th, 2024 6:42 pm
Cassava Sciences update: SAVA stock price collapses after much-criticized Alzheimer’s drug flops - Nov 25th, 2024 5:31 pm
Cassava Sciences Stock Slides 84% as Alzheimer’s Trial Fails - Nov 25th, 2024 3:06 pm
Cassava Sciences Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Pharma Halts Late-Stage Studies - Nov 25th, 2024 2:27 pm
Cassava Stock Plunges as Alzheimer's Drug Fails Late-Stage Study - Nov 25th, 2024 2:19 pm
Cassava Sciences Topline Phase 3 Data Did Not Meet Co-Primary Endpoints - Nov 25th, 2024 12:30 pm
Cassava Sciences to Hold Corporate Update on November 25th - Nov 25th, 2024 1:01 am
Cassava Sciences Appoints Freda Nassif as Chief Commercial Officer - Nov 18th, 2024 1:30 pm
Is Cassava Sciences (SAVA) Outperforming Other Medical Stocks This Year? - Nov 15th, 2024 2:40 pm
What Makes Cassava Sciences (SAVA) a New Buy Stock - Nov 12th, 2024 5:00 pm
Cassava Sciences Reports Q3 2024 Financial and Operating Results - Nov 7th, 2024 12:55 pm
Cassava Sciences to Report Third Quarter 2024 Results on November 7, 2024 - Oct 31st, 2024 12:30 pm
Institutions along with individual investors who hold considerable shares inCassava Sciences, Inc. (NASDAQ:SAVA) come under pressure; lose 6.7% of holdings value - Oct 30th, 2024 1:47 pm
MIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic Pain - Oct 28th, 2024 5:41 pm